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Treatment: He was started on cortisone, and later thyroxine replacement therapy, with prompt improvement in well-being, weight gain, and rise in blood pressure to 140/90. (Rakieten et al. 1963) with antitumour activity (Evans et al. 1965 ).
Treatment with streptozotocin: October 1968: An initial course of three intravenous infusions of streptozotocin (2 g, 2 g, 4 g; 2-hour infusion time) was ineffective. December 1968: A second course of three infusions (1 g, 2 g, 1-5 g; 10-min infusion time) given through an indwelling catheter into the coeliac axis increased blood glucose and reduced plasma insulin levels, but diazoxide therapy was still necessary. March 1969: A third course of seven infusions (2-5 g each; 10-min infusion time) given into the coeliac axis gave dramatic improvement and allowed us to discontinue diazoxide. For seven months he was normoglycmmic, but then he deteriorated and diazoxide was reintroduced. March 1970: A fourth course of four intravenous infusions (2 g, 2 g, 2 g, 4 g; 10-min infusion time) restored normal blood glucose levels but diazoxide could not be withdrawn. Coeliac axis arteriography before and after each intra-arterial course of streptozotocin showed progressive reduction in the vascularity of hepatic metastases. Mild hepatic and renal injury were temporary side-effects after the third and fourth courses of treatment.
Comment
Response to streptozotocin may depend on peak tissue levels. Rapid infusion and local administration into the cceliac axis were most effective. The cceliac axis route could minimize its renal toxicity, provided that care is taken to avoid spill over into the renal arteries.
A fuller account of this case has already been published (Stanley et al. 1970 ).
